An emerging new electrophysiology technology, known as high-density microelectrode arrays, enables researchers to study in…
Russia has established itself as a hub for neurotech startups, attracting scientists and business people…
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
In spite of recent failures of clinical trials from others in the field, Swiss company…
While the UK remains the main European hub for psychedelics research, a recent €105M Series…
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which…
Effective therapies for neurodegenerative diseases like Alzheimer's are urgently needed. But developing new drugs is…
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will…
British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US…
